EMBRACING A LEGACY
Synthimed Labs Private Limited proudly takes on the legacy of Ind-Swift Laboratories Ltd., drawing inspiration from the remarkable Indian Swiftlet – a symbol of unmatched speed, endurance, and unwavering ambition. This transition marks the beginning of a new chapter, dedicated to upholding the values of speed, growth, and perseverance.
OUR JOURNEY CONTINUES…
We are thrilled to announce that our pharmaceutical company has acquired Indswift Labs, and infused with significant investment, propelling us into an exciting new era of innovation and growth.
As we embark on this transformative journey, our unwavering commitment to excellence in pharmaceutical research, development, and production remains at the forefront of our mission. With this new investment, we are poised to expand our capabilities and deliver even more life-changing medications to those in need.
WHAT WE DO
API’s
CRAMS
IMPURITIES
R & D
Our Capabilties
State-of-the-art Manufacturing
Synthimed boasts state-of-the-art, integrated manufacturing sites that have garnered endorsements and approvals from prominent regulatory bodies worldwide, including the esteemed US Food and Drug Administration (USFDA).
Research & Development
We own a specialized Research Facility capable of managing a diverse range of complex research operations with the objective of continuously enhancing and introducing new products and process technologies.
Human Resources
We have curated a pool of skills, knowledge, talent, aptitude, and competencies through our workforce of over 3000 employees. Our employees bring a wealth of expertise and experience, enabling us to innovate and excel in serving our customers worldwide.
Global Accreditations
Synthimed, holds noteworthy global accreditations from regulatory agencies such as USFDA, EDQM, ANVISA, and KFDA, among others. These accreditations showcase our company’s commitment to maintaining high-quality standards and regulatory compliance, ensuring that its products meet the global standards of quality and regulatory requirements.
Pioneering HealthCARE Solutions for Tomorrow
Our unwavering commitment to excellence in pharmaceutical research, development, and production remains at the forefront of our mission. With this new investment, we are poised to expand our capabilities and deliver even more life-changing medications to those in need.
EXPERIENCE
Years in the Pharma Industry
GLOBAL PRESENCE
Countries We Serve
FACILITIES
Manufacturing Sites
HUMAN RESOURCE
Skilled Employees
QUALITY
International Accreditations
R&D
sqft Research & Development Centre
EXPLORE OUR PORTFOLIO
Our company has cutting-edge manufacturing facilities that allow us to meet our global goals. With a focus on obtaining consistent regulatory approvals, our products are now being distributed worldwide. Synthimed Labs, a rapidly expanding pharmaceutical company, strives to become a leading player in the global industry, and change the face of healthcare.
CarDIOVASCULAR HEALTH
ANTI-HISTAMINE
ANTI-DIABETIC
ANTI-PSYCHOTIC
ANTI- MIGRAINE
PARKINSON'S DISEASE
ANTINEOPLASTIC
ADHD SYMPTOMS
ALCOHOL ABSTINENCE
BoNE RESORPTION INHIBITOR
GLOBAL LEADER in
MACROLIDE ANTIBIOTIC SEGMENT
ESG
Synthimed’s Commitment to Sustainability
At Synthimed, our dedication to sustainability permeates every aspect of our operations. We are guided by robust policies, stringent environmental standards, dedicated in-house teams, and a culture of continuous auditing and monitoring, all aimed at upholding the principles of corporate responsibility. Our commitment to fostering sustainability goes beyond mere compliance; it is ingrained in our organizational ethos and influences every decision we make.
GLOBAL REACH
With its diverse range of high-quality products and a strong commitment to regulatory standards, Synthimed’s pharmaceutical offerings cater to the needs of a wide-ranging global customer base. Moreover, the recent acquisition of the API and CRAMS businesses of Ind-Swift Laboratories reaffirms Synthimed’s strategic efforts to enhance its global presence and serve customers with top-notch pharmaceutical products and services
Synthimed Global Reach